Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases-Reference-Cited by-同舟云学术

Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases

Published:2021-09 Issue:9 Volume:6 Page:743-753
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Eslam Mohammed,Ahmed Aijaz,Després Jean-Pierre,Jha Vivekanand,Halford Jason C G,Wei Chieh Jack Tan,Harris David C H,Nangaku Masaomi,Colagiuri Stephen,Targher Giovanni,Joshi Shashank,Byrne Christopher D,Khunti Kamlesh,Nguyen Mindie H,Gish Robert G,George Jacob

Funder

NHMRC

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference105 articles.

1. Noncommunicable diseases country profiles 2018,2018

2. Global status report on noncommunicable diseases 2014,2014

3. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study;Barnett;Lancet,2012

4. Healthy lifestyle and life expectancy in people with multimorbidity in the UK Biobank: a longitudinal cohort study;Chudasama;PLoS Med,2020

5. Aging with multimorbidity: a systematic review of the literature;Marengoni;Ageing Res Rev,2011

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features and mortality outcomes of patients with MASLD only compared to those with MAFLD and MASLD;Hepatology International;2024-08-28

2. Bringing evidence to the MAFLD‐MASLD debate;Liver International;2024-05-27

3. Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction–associated steatotic liver disease;Hepatology;2024-05-08

4. Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition;Journal of Hepatology;2024-05

5. MAFLD predicts cardiovascular disease risk better than MASLD;Liver International;2024-04-20